Mesh Payments Introduces SaaS Payment Management for Financial Optimization

Groundbreaking Suite of Capabilities Gives Finance Managers Deep Spending Insights to Manage and Continuously Optimize…

Oneview Healthcare PLC Successfully Completes A$20 Million Placement to Institutional Investors

Highlights: Oneview successfully raises A$20 million via a well-supported Placement to new and existing institutional…

mimik Technology and Claysol Media Labs Partner to Accelerate Digital Transformation via Seamless Shift to Hybrid Edge Cloud Computing

OAKLAND, Calif. & BANGALORE, India--(BUSINESS WIRE)--mimik Technology, Inc., a pioneering hybrid edge cloud company, and…

Cloudflare Makes it Easy for Developers to Build Any Application on Its Industry-Leading Serverless Platform

Surpasses more than two million applications across Cloudflare’s global platform and announces new tools, integrations,…

Mawson Infrastructure Group Announces Financial Results for Third Quarter 2021

Revenue of $10.9 Million, up 1100% vs Q3 2020 Gross Profit of $8.4 Million, up…

CyberLink’s FaceMe® Certified by iBeta – Anti-Spoofing Technology Detects & Rejects 100% of Facial Presentation Attacks

Perfect score at ISO-conforming iBeta’s liveness detection test cements FaceMe technology’s leadership TAIPEI, Taiwan--(BUSINESS WIRE)--#CyberLink--CyberLink…

Hyosung Chairman Cho Hyun-joon Leads Company’s Record-high Performance in Q3 With Advanced Materials

SEOUL, South Korea--(BUSINESS WIRE)--#ChairmanChoHyunJoon--Having produced a record-high performance in the first half of this year…

Launch of Out of Bounds: TFAM Expansion

Moving beyond imagination, expanding art into the unknown TAIPEI, Taiwan--(BUSINESS WIRE)--#TaipeiFineArtsMuseum--Following several years of preparation,…

Insights on the Biological Organic Fertilizers Global Market to 2027 – Industry Trends, Share, Insights and Impact of COVID-19 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Biological Organic Fertilizers Market Global Forecast 2021-2027, Industry Trends, Share, Insight, Impact of…

RIBOMIC Announces RBM-007 Phase 1 Clinical Trial Results for Achondroplasia

TOKYO--(BUSINESS WIRE)--RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics (TYO:4591), announced the…